Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ANDRESENS BIOENERGI A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.7% 2.7%   Bankruptcy risk   5.2% 4.7% 4.0% 5.0% 7.6% 4.1% 14.0% 14.0%   Credit score (0-100)   44 47 50 42 31 48 16 16   Credit rating   BBB BBB BBB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   913 644 432 342 168 410 0.0 0.0   EBITDA   -15.2 180 6.6 -118 -273 34.1 0.0 0.0   EBIT   -115 98.0 1.6 -122 -275 29.1 0.0 0.0   Pre-tax profit (PTP)   -131.3 70.6 -24.2 -143.2 -295.8 1.7 0.0 0.0   Net earnings   -130.8 70.9 -22.2 -141.1 -292.3 4.3 0.0 0.0   Pre-tax profit without non-rec. items   -131 70.6 -24.2 -143 -296 1.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   55.5 10.5 5.5 1.6 54.1 0.0 0.0 0.0   Shareholders equity total   335 406 384 243 -49.6 455 -45.3 -45.3   Interest-bearing liabilities   422 456 474 541 607 125 100 100   Balance sheet total (assets)   1,340 1,312 1,432 1,085 751 758 55.0 55.0   Net Debt   33.8 250 -20.6 383 493 52.1 100 100     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   913 644 432 342 168 410 0.0 0.0   Gross profit growth   -9.8% -29.5% -32.8% -20.9% -50.8% 143.8% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,340 1,312 1,432 1,085 751 758 55 55   Balance sheet change%   -9.7% -2.1% 9.1% -24.2% -30.8% 1.0% -92.7% 0.0%   Added value   -15.2 180.5 6.6 -117.9 -271.6 34.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -197 -165 -10 -8 50 -4 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -12.5% 15.2% 0.4% -35.6% -163.9% 7.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -7.3% 7.5% 0.1% -9.5% -28.1% 3.7% 0.0% 0.0%   ROI %   -12.1% 12.2% 0.2% -14.5% -38.2% 4.9% 0.0% 0.0%   ROE %   -32.7% 19.1% -5.6% -45.0% -58.8% 0.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   25.0% 30.9% 26.8% 22.4% -6.2% 60.0% -45.2% -45.2%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -222.9% 138.7% -311.2% -324.6% -180.7% 152.8% 0.0% 0.0%   Gearing %   125.9% 112.4% 123.6% 222.9% -1,223.8% 27.5% -221.4% -221.4%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.0% 6.5% 5.6% 4.7% 5.3% 7.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 0.9 0.9 0.8 0.5 1.2 0.0 0.0   Current Ratio   1.2 1.4 1.3 1.2 0.8 2.2 0.0 0.0   Cash and cash equivalent   388.1 205.8 494.7 158.1 114.2 73.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   172.1 325.4 308.3 171.1 -173.7 359.7 -50.2 -50.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 34 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 34 0 0   EBIT / employee   0 0 0 0 0 29 0 0   Net earnings / employee   0 0 0 0 0 4 0 0